| Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis (NCT02183064) | Boehringer Ingelheim | 1998-10-01 |
| Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients (NCT02184078) | Boehringer Ingelheim | 1998-10-01 |
| A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee (NCT02183116) | Boehringer Ingelheim | 1998-10-01 |
| Ketoprofen Lysine Salt as Mouthwash in Acute Phlogosis of the Pharyngeal Cavity Versus Benzidamine Hydrochloride (NCT02178293) | Boehringer Ingelheim | 1998-09-01 |
| Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma (NCT02182505) | Boehringer Ingelheim | 1998-09-01 |
| Bioavailability of Ibuprofen Enantiomers Compared With Standard Brufen Sirup in Healthy Male Volunteers (NCT02182960) | Boehringer Ingelheim | 1998-09-01 |
| Telmisartan/Hydrochlorothiazide (HCTZ) Fixed Dose Combination Compared to Its Monocomponents in Healthy Subjects (NCT02176512) | Boehringer Ingelheim | 1998-09-01 |
| Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy Subjects (NCT02183077) | Boehringer Ingelheim | 1998-09-01 |
| Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children (NCT02235428) | Boehringer Ingelheim | 1998-09-01 |
| Tolerability and Pharmacokinetics of Telmisartan in Combination With Lacidipine in Healthy Male Subjects (NCT02218684) | Boehringer Ingelheim | 1998-09-01 |
| Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients (NCT02183688) | Boehringer Ingelheim | 1998-09-01 |
| BIBR 277 Capsule in Patients With Essential Hypertension (NCT02177448) | Boehringer Ingelheim | 1998-09-01 |
| Dose Escalation Study to Evaluate Safety and Tolerability of an Allogeneic Tumor Vaccine BIWB 2 in Patients With Advanced Malignant Melanoma (NCT02203864) | Boehringer Ingelheim | 1998-08-01 |
| Safety and Efficacy of Two Different Doses of Ipratropium Bromide Versus ATROVENT® Inhalation Aerosol in Adults With Chronic Obstructive Pulmonary Disease (NCT02177344) | Boehringer Ingelheim | 1998-08-01 |
| FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia (NCT02244255) | Boehringer Ingelheim | 1998-08-01 |
| BIBR 277 Capsules in Hypertensive Patients With Nephropathy (NCT02187484) | Boehringer Ingelheim | 1998-08-01 |
| Ba253BINEB in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02182635) | Boehringer Ingelheim | 1998-08-01 |
| Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers (NCT02264067) | Boehringer Ingelheim | 1998-07-01 |
| A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma (NCT02182661) | Boehringer Ingelheim | 1998-07-01 |
| Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection (NCT02199886) | Boehringer Ingelheim | 1998-07-01 |
| Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT02244242) | Boehringer Ingelheim | 1998-07-01 |
| Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis (NCT02182700) | Boehringer Ingelheim | 1998-07-01 |
| Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT02172352) | Boehringer Ingelheim | 1998-07-01 |
| Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male Subjects (NCT02266485) | Boehringer Ingelheim | 1998-07-01 |
| Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis (NCT02183038) | Boehringer Ingelheim | 1998-07-01 |
| Study to Assess the Safety of Ipratropium Bromide, in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02236182) | Boehringer Ingelheim | 1998-07-01 |
| Safety, Tolerability, Biological Effects and Pharmacokinetics of BIIL 284 BS in Healthy Males (NCT02265302) | Boehringer Ingelheim | 1998-06-01 |
| Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease (NCT02233023) | Boehringer Ingelheim | 1998-06-01 |
| Safety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male Volunteers (NCT02199873) | Boehringer Ingelheim | 1998-06-01 |
| Study to Determine Tolerability After Intravenous Administration of BIBN 4096 BS in Healthy Male and Female Volunteers (NCT02198352) | Boehringer Ingelheim | 1998-06-01 |
| Pharmacokinetics of BIBR 277 in Hypertensive Patients (NCT02187497) | Boehringer Ingelheim | 1998-06-01 |
| Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects (NCT02266498) | Boehringer Ingelheim | 1998-06-01 |
| Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension (NCT02235415) | Boehringer Ingelheim | 1998-06-01 |
| Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension (NCT02177422) | Boehringer Ingelheim | 1998-06-01 |
| Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm (NCT02182713) | Boehringer Ingelheim | 1998-05-01 |
| Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects (NCT02264197) | Boehringer Ingelheim | 1998-05-01 |
| Effect of Caldine® on Renal Function in Balanced Hypertension (NCT02240641) | Boehringer Ingelheim | 1998-05-01 |
| Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension (NCT02223481) | Boehringer Ingelheim | 1998-05-01 |
| The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances (NCT02183714) | Boehringer Ingelheim | 1998-05-01 |
| Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine (VIRAMUNE) and Ethinyl Estradiol/Norethindrone in HIV-1 Infected Women (NCT02182791) | Boehringer Ingelheim | 1998-04-01 |
| Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients (NCT02182479) | Boehringer Ingelheim | 1998-04-01 |
| The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects (NCT02172339) | Boehringer Ingelheim | 1998-04-01 |
| Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients (NCT02244229) | Boehringer Ingelheim | 1998-04-01 |
| Bioavailability of Two Sustained-release Theophylline Products in Healthy Males (NCT02184247) | Boehringer Ingelheim | 1998-04-01 |
| Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban in Healthy Subjects (NCT02264119) | Boehringer Ingelheim | 1998-04-01 |
| Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension (NCT02177409) | Boehringer Ingelheim | 1998-04-01 |
| Efficacy and Safety of Lacidipine in Chronic Stable Angina (NCT02232607) | Boehringer Ingelheim | 1998-04-01 |
| Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy Subjects (NCT02264106) | Boehringer Ingelheim | 1998-04-01 |
| Antistax® in Patients With Chronic Venous Insufficiency (NCT02191280) | Boehringer Ingelheim | 1998-04-01 |
| Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension (NCT02183701) | Boehringer Ingelheim | 1998-04-01 |
| Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar (NCT02183051) | Boehringer Ingelheim | 1998-04-01 |
| MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (NCT02177396) | Boehringer Ingelheim | 1998-04-01 |
| Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02175342) | Boehringer Ingelheim | 1998-03-01 |
| Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects (NCT02259985) | Boehringer Ingelheim | 1998-03-01 |
| Relative Bioavailability and Tolerability of Various Experimental Formulations of BIBV 308 SE in Healthy Subjects (NCT02223000) | Boehringer Ingelheim | 1998-03-01 |
| Pharmacokinetic-pharmacodynamic Assessment of Seresis® in Healthy Volunteers (NCT02191787) | Boehringer Ingelheim | 1998-03-01 |
| Comparison of Safety and Efficacy of Berodual® Administered Via the Respimat® Device With That Administered Via the Metered Dose Inhaler (MDI) in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02173782) | Boehringer Ingelheim | 1998-02-01 |
| Pharmacokinetic Study in Elderly Patients With Chronic Obstructive Bronchitis (COPD) (NCT02172326) | Boehringer Ingelheim | 1998-02-01 |
| Study to Assess the Kinetic of the Analgesic Effect and Tolerability of Eschscholtzia Californica Versus Ibuprofen and Placebo in the Treatment of Pain After Surgery of the Third Molar (NCT02187588) | Boehringer Ingelheim | 1998-02-01 |
| A Study of Pre-hospital Treatment of Acute Myocardial Infarction Based on Diagnosis by Interpretation of Remotely Acquired ECG and Thrombolysis With Accelerated Alteplase ( Actilyse®) (NCT02235389) | Boehringer Ingelheim | 1998-02-01 |
| Ipratropium or Salbutamol Sulphate Alone or Combination Therapy Salbutamol and Ipratropium in Patients With COPD (NCT02182856) | Boehringer Ingelheim | 1998-02-01 |
| Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms (NCT02229786) | Boehringer Ingelheim | 1998-02-01 |
| Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea (NCT02183025) | Boehringer Ingelheim | 1998-01-01 |
| Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia (NCT02183233) | Boehringer Ingelheim | 1998-01-01 |
| A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients (NCT02235402) | Boehringer Ingelheim | 1997-12-01 |
| Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00003328) | Boehringer Ingelheim | 1997-12-01 |
| DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril (NCT00274118) | Boehringer Ingelheim | 1997-07-01 |
| Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension (NCT02177331) | Boehringer Ingelheim | 1995-06-01 |
| Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma (NCT02177370) | Boehringer Ingelheim | 1990-02-01 |
| The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine (NCT00002381) | Boehringer Ingelheim | |
| An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease (NCT00002166) | Boehringer Ingelheim | |
| A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ Cell (NCT00002323) | Boehringer Ingelheim | |
| Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment (NCT00651183) | Boehringer Ingelheim | |
| An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities (NCT03843892) | Boehringer Ingelheim | |
| Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP) (NCT02171156) | Boehringer Ingelheim | |
| An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3) (NCT00000649) | Boehringer Ingelheim | |
| The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs (NCT00002368) | Boehringer Ingelheim | |
| The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease (NCT00002324) | Boehringer Ingelheim | |
| A Treatment Protocol to Support the Care of Children and Adolescents With Fibrosing Interstitial Lung Disease (ILD) (NCT05624281) | Boehringer Ingelheim | |
| Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics (NCT00268866) | Boehringer Ingelheim | |
| Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (NCT02230982) | Boehringer Ingelheim | |
| Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC) (NCT01931306) | Boehringer Ingelheim | |
| RUSSE / Russian Spiriva® Safety & Efficacy Study (NCT00613574) | Boehringer Ingelheim | |
| An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options (NCT04739150) | Boehringer Ingelheim | |
| An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. (NCT00002194) | Boehringer Ingelheim | |
| LUX Lung Special Access Scheme Australia Named Patient Use (NPU) (NCT01209650) | Boehringer Ingelheim | |
| Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors) (NCT05107193) | Boehringer Ingelheim | |